SCHEMBL11705642

SCHEMBL11705642

CN(C)C(c1cccnc1)C1CCCCC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
TSHR P16473 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
OPRM1 P35372 2/20 0.44
CYP2C9 P11712 1/20 0.44
OPRD1 P41143 1/20 0.44
MAPT P10636 3/20 0.44
HSD17B10 Q99714 1/20 0.44
CA1 P00915 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ADRB3 P13945 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375903 0.84 CA1 (0.55) ALDH1A1MAPTCA1SMN1; SMN2KDM4E
SCHEMBL11794387 0.83 CA1 (0.54) ALDH1A1MAPTCA1SMN1; SMN2KDM4E
SCHEMBL6676417 0.78 CA1 (0.43) ALDH1A1OPRM1MAPTCA1SMN1; SMN2
SCHEMBL6943357 0.77 MAPT (0.46) ALDH1A1OPRM1OPRD1MAPTCA1
SCHEMBL6676360 0.77 OPRL1 (0.44) ALDH1A1TSHROPRM1OPRD1MAPT
SCHEMBL6938929 0.76 MAPT (0.50) ALDH1A1CYP3A4CYP2C19MAPTCA1
SCHEMBL6942334 0.76 MAPT (0.50) ALDH1A1MAPTCA1SMN1; SMN2KDM4E
SCHEMBL6934444 0.76 ALDH1A1 (0.44) ALDH1A1MAPTCA1SMN1; SMN2KDM4E
SCHEMBL6676434 0.75 ALDH1A1 (0.49) ALDH1A1OPRM1CA1
SCHEMBL11709049 0.75 OPRM1 (0.60) ALDH1A1TSHRCYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4021560-A ANALGESICS AMERICAN HOME PRODUCTS CORPORATION (US) 1977-05-03 US disclosed